While these questions are being investigated, c9RAN proteins should be explored as a biomarker for c9FTD/ALS, as should treatment strategies aimed at eradicating the putatively toxic sense and antisense transcripts responsible for both foci formation and RAN translation. The gene discussed is RAN; the disease is amyotrophic lateral sclerosis.